SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/B3E8B3F301F45F7EE46F28A0C8FAEAC68F1AA81A6D4D2B54B1FE446C676E95E387AB4B18434F8C9E3E440D9303614350>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/B3E8B3F301F45F7EE46F28A0C8FAEAC68F1AA81A6D4D2B54B1FE446C676E95E387AB4B18434F8C9E3E440D9303614350
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/B3E8B3F301F45F7EE46F28A0C8FAEAC68F1AA81A6D4D2B54B1FE446C676E95E387AB4B18434F8C9E3E440D9303614350
http://www.w3.org/2000/01/rdf-schema#comment
"Bortezomib inhibits EIU probably by inhibiting the activation of NF-kappaB which in turn down-regulates the expression of the associated inflammatory genes."
xsd:string
http://purl.uniprot.org/uniprot/#_5CB42805D206ADD5626D5C8457ACA8CE07B6CD89E06571D5B5E3964C9125C569F88D381B373DC2C67CAF4994BA2F101B
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/B3E8B3F301F45F7EE46F28A0C8FAEAC68F1AA81A6D4D2B54B1FE446C676E95E387AB4B18434F8C9E3E440D9303614350
http://purl.uniprot.org/uniprot/Q63369
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B3E8B3F301F45F7EE46F28A0C8FAEAC68F1AA81A6D4D2B54B1FE446C676E95E387AB4B18434F8C9E3E440D9303614350
http://purl.uniprot.org/uniprot/#_Q63369-mappedCitation-22538426
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B3E8B3F301F45F7EE46F28A0C8FAEAC68F1AA81A6D4D2B54B1FE446C676E95E387AB4B18434F8C9E3E440D9303614350